Product
Hepatitis B vaccine
Aliases
Commercial Hepatitis B vaccine, Engerix B, Engerix-B, hepatitis B vaccine (4 other aliases)
Name
ENGERIX-B
INN Name
Hepatitis B Vaccine (Recombinant)
FDA Approved
Yes
9 clinical trials
1 organization
9 indications
1 document
Indication
Healthy Control ParticipantsIndication
Chronic Hepatitis BIndication
Adverse Reaction to ImmunizationIndication
Adverse Vaccine ReactionIndication
Volunteers (Meningococcal Infection)Indication
Genital WartsIndication
Respiratory Syncytial Virus ImmunizationIndication
Newborn Vaccine ImmunogenicityIndication
Inflammatory Bowel DiseaseClinical trial
Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)Status: Terminated, Estimated PCD: 2011-03-11
Clinical trial
A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus InfectionStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
Immunogenicity and Safety Following In-House Recombinant Hepatitis B (Bio Farma) Vaccine Compared to Hepatitis B (Bio Farma)® Vaccine in Indonesian PopulationStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Clinical trial
A Phase III, Partially Modified Double-blind, Randomized, Parallel-group, Active-controlled, Multi-center Study to Compare the Immunogenicity and Describe the Safety of MenACYW Conjugate Vaccine and MENVEO® When Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in the United StatesStatus: Completed, Estimated PCD: 2023-09-22
Clinical trial
Prophylactic Vaccines as Therapy: Prevention of Recurrence of Extensive Genital WartsStatus: Active (not recruiting), Estimated PCD: 2025-05-31
Clinical trial
Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL)Status: Recruiting, Estimated PCD: 2025-09-30
Clinical trial
Systems Biology to Identify Biomarkers of Neonatal Vaccine ImmunogenicityStatus: Completed, Estimated PCD: 2022-08-29
Clinical trial
Peri-conceptional or Pregnancy Exposure of Vaccination and the Risk of Adverse Pregnancy OutcomesStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Efficacy of Accelerated Versus Standard Regiment of Hepatitis B Virus Vaccine Among Inflammatory Bowel Disease PatientsStatus: Not yet recruiting, Estimated PCD: 2024-09-01
Document
DailyMed Label: ENGERIX-BOrganization
Dispensing Solutions Inc.